NCT06476665View on ClinicalTrials.gov

A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.

Active, not recruitingOBSERVATIONAL

Enrollment

7

Participants

Timeline

Start Date

November 7, 2024

Primary Completion Date

June 22, 2029

Study Completion Date

June 22, 2029

Conditions

Acute Lymphocytic Leukemia

Trial Locations (1)

Unknown

Pfizer, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY